Western blot analysis using anti-ANGPTL4 (CCD) (human), pAb (Prod. No. AG-25A-0066) at 1:2000 dilution. 1: Human ANGPTL4 (CDD) (FLAG®-tagged). 2: Human ANGPTL4 (FLAG®-tagged). 3: Human ANGPTL3 (CCD) (FLAG®
anti-ANGPTL4 (coiled-coil domain) (human), pAb
AG-25A-0066
ApplicationsWestern Blot, ELISA
Product group Antibodies
ReactivityHuman
TargetANGPTL4
Overview
- SupplierAdipoGen Life Sciences
- Product Nameanti-ANGPTL4 (coiled-coil domain) (human), pAb
- Delivery Days Customer10
- Antibody SpecificityRecognizes the coiled-coil domain of human ANGPTL4. Detects a band of ~19kDa by Western blot. Weakly cross-reacts with human ANGPTL2 (coiled-coil domain), ANGPTL3 and ANGPTL5 (coiled-coil domain).
- ApplicationsWestern Blot, ELISA
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 mg/ml
- FormulationLiquid
- Gene ID51129
- Target nameANGPTL4
- Target descriptionangiopoietin like 4
- Target synonymsangiopoietin-related protein 4; ARP4; fasting-induced adipose factor; FIAF; HARP; hepatic angiopoietin-related protein; hepatic fibrinogen/angiopoietin-related protein; HFARP; NL2; peroxisome proliferator-activated receptor (PPAR) gamma induced angiopoietin-related protein; PGAR; pp1158; PPARG angiopoietin related protein; TGQTL; UNQ171
- HostRabbit
- Protein IDQ9BY76
- Protein NameAngiopoietin-related protein 4
- Scientific DescriptionANGPTL4 mainly expressed in endothelial cells (hypoxia-induced). Regulates angiogenesis and modulates tumorgenesis and directly regulates lipid, glucose, and energy metabolism. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. ANGPTL4 is a protein consisting of an N-terminal coiled-coil domain and a C-terminal fibrinogen-like domain (FLD). Both domains have distinct biological functions. The coiled-coil domain is responsible for the inhibitory effects on lipoprotein lipase (LPL) converting the active form of LPL into an inactive form, and the FLD domain mediates its antiangiogenic functions. The coiled coil and the FLD domains are separated by a short linker that can be cleaved after secretion. ANGPTL4 appears on the cell surface as the full-length form, where it can be released by heparin treatment. ANGPTL4 protein is then proteolytically cleaved by proprotein convertases (PCs), including furin, PC5/6, paired basic amino acid-cleaving enzyme 4, and PC7. - Polyclonal Antibody. Recognizes the coiled-coil domain of human ANGPTL4. Detects a band of ~19kDa by Western blot. Weakly cross-reacts with human ANGPTL2 (coiled-coil domain), ANGPTL3 and ANGPTL5 (coiled-coil domain). Source: Rabbit. Applications: ELISA, WB. Liquid. 0.2microm-filtered solution in PBS, pH 7.4. Contains no preservatives. ANGPTL4 mainly expressed in endothelial cells (hypoxia-induced). Regulates angiogenesis and modulates tumorgenesis and directly regulates lipid, glucose, and energy metabolism. Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. ANGPTL4 is a protein consisting of an N-terminal coiled-coil domain and a C-terminal fibrinogen-like domain (FLD). Both domains have distinct biological functions. The coiled-coil domain is responsible for the inhibitory effects on lipoprotein lipase (LPL) converting the active form of LPL into an inactive form, and the FLD domain mediates its antiangiogenic functions. The coiled coil and the FLD domains are separated by a short linker that can be cleaved after secretion. ANGPTL4 appears on the cell surface as the full-length form, where it can be released by heparin treatment. ANGPTL4 protein is then proteolytically cleaved by proprotein convertases (PCs), including furin, PC5/6, paired basic amino acid-cleaving enzyme 4, and PC7.
- ReactivityHuman
- Storage Instruction-20°C,2°C to 8°C
- UNSPSC12352203